Cancer Targeted Gene Panel: Colon / Colorectal ₹15960

The Cancer Targeted Gene Panel: Colon / Colorectal analyzes multiple cancer-related genes using Next Generation Sequencing (NGS) to identify clinically significant mutations associated with colorectal cancer. The results help guide personalized treatment, targeted therapy selection, prognosis, and clinical decision-making.

Book on WhatsApp Call Now

Advanced NGS Cancer Test • Doctor Prescription Recommended

Quick Details

Test Price ₹15960

Fasting Required No

Sample Type Tumor Tissue (FFPE) / Blood*

Report Time 10–21 Working Days*

What is the Cancer Targeted Gene Panel: Colon / Colorectal?

The Colon / Colorectal Cancer Targeted Gene Panel is a comprehensive molecular test that evaluates multiple genes known to play an important role in colorectal cancer. Using Next Generation Sequencing (NGS), the test detects genetic alterations that may influence cancer behavior, prognosis, and eligibility for targeted therapies. It supports precision oncology by helping oncologists select the most appropriate treatment strategy for each patient.

Who should consider this test?

Patients diagnosed with colon cancer.
Patients diagnosed with colorectal cancer.
Individuals with advanced or metastatic colorectal cancer.
Patients being evaluated for targeted therapy or immunotherapy.
Patients whose oncologist recommends molecular profiling.
Individuals requiring precision medicine treatment planning.

Preparation & Test Process

Sample Required

FFPE tumor tissue is commonly required. Blood samples may be accepted for selected clinical indications.

Fasting

No fasting is required.

Technology

Performed using high-quality Next Generation Sequencing (NGS) technology.

Important Note

This test should be ordered and interpreted by an oncologist or clinical genetic specialist.

Understanding Your Results

The report identifies clinically important genetic mutations associated with colorectal cancer.

Results may help determine:

Eligibility for targeted therapies.
Potential response to immunotherapy.
Prognostic information.
Availability of precision medicine treatment options.
Suitability for clinical trials.

Results should always be interpreted together with pathology findings, imaging studies, clinical history, and oncologist recommendations.

FAQs – Cancer Targeted Gene Panel: Colon / Colorectal

It detects multiple clinically significant gene mutations associated with colorectal cancer using Next Generation Sequencing (NGS).

It is commonly recommended for patients with newly diagnosed, recurrent, advanced, or metastatic colorectal cancer.

No. Fasting is generally not required.

Yes. The identified mutations may help your oncologist determine eligibility for targeted therapies, immunotherapy, and personalized treatment options.

Book on WhatsApp Call Now

Related diagnostic tests

CSF MICROPROTEIN CSF CRP CSF CHLORIDE CSF BIOCHEMISTRY cryptococcus serum

Book Cancer Targeted Gene Panel: Colon Colorectal in Chandigarh

Home collection · Digital reports · 24–48 hours

WhatsApp to book Call 7087015736

Disclaimer: This page is for informational purposes only. Consult your doctor for medical advice. All tests processed with NABL-aligned quality standards.